二尖瓣狭窄

Oct. 08, 2026

妙佑医疗国际的二尖瓣狭窄护理

妙佑医疗国际医护团队

妙佑医疗国际在心脏病领域训练有素的医生(心脏科医生)会与心脏外科医生(心血管外科医生)和其他医疗护理专业人员组成多学科团队通力合作,以向您提供协调全面的护理。

将所有这些专业技能汇集一处意味着整个团队会讨论您的医疗护理。协调安排就诊。迅速提供检查结果。全球最专业的心脏病专家将通力合作改善您的健康状况。

  • 个体化方法。 妙佑医疗国际的医疗护理专业人员将为您提供全人护理。他们会花时间了解您的情况,与您合作,针对您的需求提供适当护理。
  • 创新的治疗。 妙佑医疗国际的外科医生均接受过创新技术培训,可开展 mitral valve repair and mitral valve replacement 和其他心脏瓣膜手术。在可能的情况下,外科医生会对二尖瓣进行修复,而不是置换。二尖瓣修复术可以保住瓣膜,并可能维持心脏功能。
  • 先进的诊断。 妙佑医疗国际的医疗护理专业人员使用高级成像技术(包括超声心动图、三维超声心动图和经食管超声心动图)来准确诊断二尖瓣狭窄和其他心脏状况。这些技术还可能有助于确定心脏瓣膜病的病因。

专业技能和排名

妙佑医疗国际的心脏科医生和心血管外科医生在评估和治疗包括二尖瓣狭窄在内的心脏瓣膜病患者方面经验丰富。瓣膜性心脏病专科门诊的外科医生在二尖瓣修复和置换方面经验丰富。每年,妙佑医疗的医疗护理专业人员评估和治疗的二尖瓣狭窄患者超过 850 人。

在治疗有心脏状况的儿童方面训练有素的医生(称为儿科心脏科医生)会与妙佑医疗国际明尼苏达州院区的儿科心血管外科医生合作治疗患有二尖瓣狭窄和其他心脏状况的儿童。

  1. Ferri FF. Mitral stenosis. In: Ferri's Clinical Advisor 2023. Elsevier; 2023. https://www.clinicalkey.com. Accessed Aug. 2, 2022.
  2. Libby P, et al., eds. Mitral stenosis. In: Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 12th ed. Elsevier; 2022. https://www.clinicalkey.com. Accessed Aug. 2, 2022.
  3. Heart valve diseases. National Heart, Lung, and Blood Institute. https://www.nhlbi.nih.gov/health/heart-valve-diseases. Accessed Aug. 2, 2022.
  4. Mitral stenosis. Merck Manual Professional Version. https://www.merckmanuals.com/professional/cardiovascular-disorders/valvular-disorders/mitral-stenosis. Accessed Aug. 2, 2022.
  5. Meyer TE. Pathophysiology and natural history of mitral stenosis. https://www.uptodate.com/contents/search. Accessed Aug. 2, 2022.
  6. Otto CM, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2021; doi:10.1016/j.jacc.2020.11.018.
  7. Goldman L, et al., eds. Valvular heart disease. In: Goldman-Cecil Medicine. 26th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed Aug. 2, 2022.
  8. Problem: Mitral valve stenosis. American Heart Association. https://www.heart.org/en/health-topics/heart-valve-problems-and-disease/heart-valve-problems-and-causes/problem-mitral-valve-stenosis. Accessed Aug. 2, 2022.
  9. Meyer TE. Rheumatic mitral stenosis: Overview of management. https://www.uptodate.com/contents/search. Accessed Aug. 2, 2022.
  10. Ami TR. Allscripts EPSi. Mayo Clinic. April 29, 2024.
  11. American Heart Association adds sleep to cardiovascular health checklist. American Heart Association. https://newsroom.heart.org/news/american-heart-association-adds-sleep-to-cardiovascular-health-checklist. Accessed July 15, 2022.
  12. Lloyd-Jones DM, et al. Life's essential 8: Updating and enhancing the American Heart Association's construct of cardiovascular health: A presidential advisory from the American Heart Association. Circulation. 2022; doi:10.1161/CIR.0000000000001078.
  13. How blood flows through the heart. American Heart Association. https://www.nhlbi.nih.gov/health/heart/blood-flow. Accessed Aug. 3, 2022.
  14. Fortier JH, et al. Drug-associated valvular heart diseases and serotonin-related pathways: A meta-analysis. Heart. 2019; doi:10.1136/heartjnl-2018-314403.
  15. Medical review (expert opinion). Mayo Clinic. Aug. 31, 2022.
  16. Centers for Disease Control and Prevention (CDC). Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S. Department of Health and Human Services interim public health recommendations, November 1997. MMWR Morbidity and Mortality Weekly Report. 1997. https://www.cdc.gov/mmwr/preview/mmwrhtml/00049815.htm. Accessed Sept. 1, 2022.
  17. Meyer TE, et al. Valvular heart disease induced by drugs. https://www.uptodate.com/contents/search. Accessed Aug. 2, 2022.
  18. Connolly HM, et al. Valvular heart disease associated with fenfluramine-phentermine. New England Journal of Medicine. 1997; doi:10.1056/NEJM199708283370901.